18
What is the prevalence of Shigellosis?
How many people does Shigellosis affect? Does it have the same prevalence in men and women? And in the different countries?
Shigellosis is a highly contagious bacterial infection caused by the Shigella bacteria. It is a significant global health concern, particularly in developing countries with poor sanitation and hygiene practices. The prevalence of Shigellosis varies geographically, with an estimated annual global incidence of 80 to 165 million cases. It is responsible for approximately 600,000 deaths each year, primarily affecting young children. The transmission occurs through the fecal-oral route, often due to contaminated food or water. Preventive measures such as improved sanitation, hand hygiene, and safe food practices are crucial in reducing the burden of this infectious disease.
Shigellosis, also known as bacillary dysentery, is a highly contagious bacterial infection caused by the Shigella bacteria. It primarily affects the gastrointestinal tract, leading to symptoms such as severe diarrhea, abdominal cramps, fever, and vomiting. Shigellosis is a significant global health concern, particularly in developing countries with poor sanitation and hygiene practices.
The prevalence of Shigellosis varies across different regions and populations. According to the World Health Organization (WHO), it is estimated that there are approximately 80 to 165 million cases of Shigellosis worldwide each year. However, due to underreporting and limited surveillance systems in some areas, the actual number of cases could be much higher.
Shigellosis is more common in children under the age of 5 and individuals living in crowded conditions. It can spread easily through contaminated food, water, or direct contact with infected individuals. The bacteria are highly infectious, with a low number of organisms required to cause illness.
Preventing Shigellosis involves practicing good hygiene, such as frequent handwashing, proper food handling, and safe water sources. Treatment typically involves antibiotics to reduce the duration and severity of symptoms. However, the emergence of drug-resistant strains poses challenges in managing and controlling the disease.
Diseasemaps
